Lojuxta Европска Унија - Енглески - EMA (European Medicines Agency)

lojuxta

amryt pharmaceuticals dac - lomitapide - hypercholesterolemia - lipid modifying agents - lojuxta is indicated as an adjunct to a low‑fat diet and other lipid‑lowering medicinal products with or without low-density-lipoprotein (ldl) apheresis in adult patients with homozygous familial hypercholesterolaemia (hofh). genetic confirmation of hofh should be obtained whenever possible. other forms of primary hyperlipoproteinaemia and secondary causes of hypercholesterolaemia (e.g. nephrotic syndrome, hypothyroidism) must be excluded.,

Lojuxta 5mg capsules Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

lojuxta 5mg capsules

amryt pharma - lomitapide - capsule - 5mg

Lojuxta 10mg capsules Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

lojuxta 10mg capsules

amryt pharma - lomitapide - capsule - 10mg

Lojuxta 20mg capsules Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

lojuxta 20mg capsules

amryt pharma - lomitapide - capsule - 20mg

Midazolam 1 mg/ml Solution for Injection or Infusion Ирска - Енглески - HPRA (Health Products Regulatory Authority)

midazolam 1 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - midazolam - solution for injection/infusion - 1 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

Midazolam 5 mg/ml Solution for Injection or Infusion Ирска - Енглески - HPRA (Health Products Regulatory Authority)

midazolam 5 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - midazolam - solution for injection/infusion - 5 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

Midazolam 2 mg/ml Solution for injection or infusion Ирска - Енглески - HPRA (Health Products Regulatory Authority)

midazolam 2 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - midazolam - solution for injection/infusion - 2 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

LOJUXTA 10 MG Израел - Енглески - Ministry of Health

lojuxta 10 mg

medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 10 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).

LOJUXTA 20 MG Израел - Енглески - Ministry of Health

lojuxta 20 mg

medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 20 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).

LOJUXTA 5 MG Израел - Енглески - Ministry of Health

lojuxta 5 mg

medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 5 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).